Increased expression of cancer stem cell marker CD133; increased expression of pluripotent factors OCT4, NANOG, and SOX2; induced EMT; repression of G2/M cell-cycle arrest; reduced apoptosis rate. The gene discussed is PROM1; the disease is cancer.